FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1166.171
Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1166.171 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1166.171/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.171 |
Version | 20211012 |
Status | active |
Date | 2021-10-12T01:01:38-04:00 |
Name | ContraceptiveImplantICD10CMSurveillance |
Title | Contraceptive Implant ICD10CM Surveillance |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: Family planning - provision and use of most and moderately effective contraceptive methods),(Data Element Scope: Procedure codes related to surveillance of contraceptive implant, a most effective method of contraception),(Inclusion Criteria: Procedure codes related to surveillance of contraceptive implant, a most effective method of contraception),(Exclusion Criteria: Any contraceptive method that is not a contraceptive implant; Most effective (i.e., sterilization, intrauterine devices or systems) or moderately effective (i.e., injectables, oral pills, patch, or ring) methods of contraception; Less effective methods of contraception (i.e., diaphragm, male condom, female condom, withdrawal, sponge, fertility-awareness based methods, spermicide)) |
Resources that use this resource
Resources that this resource uses
CodeSystem |
icd-10-cm | International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) |
Narrative
No narrative content found in resource
Source
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1166.171",
"meta": {
"versionId": "8",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "OPA Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-03-14"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2021-10-12"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.171",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1166.171"
}
],
"version": "20211012",
"name": "ContraceptiveImplantICD10CMSurveillance",
"title": "Contraceptive Implant ICD10CM Surveillance",
"status": "active",
"experimental": false,
"date": "2021-10-12T01:01:38-04:00",
"publisher": "OPA Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: Family planning - provision and use of most and moderately effective contraceptive methods),(Data Element Scope: Procedure codes related to surveillance of contraceptive implant, a most effective method of contraception),(Inclusion Criteria: Procedure codes related to surveillance of contraceptive implant, a most effective method of contraception),(Exclusion Criteria: Any contraceptive method that is not a contraceptive implant; Most effective (i.e., sterilization, intrauterine devices or systems) or moderately effective (i.e., injectables, oral pills, patch, or ring) methods of contraception; Less effective methods of contraception (i.e., diaphragm, male condom, female condom, withdrawal, sponge, fertility-awareness based methods, spermicide))",
"compose": {
"include": [
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"concept": [
{
"code": "Z30.46",
"display": "Encounter for surveillance of implantable subdermal contraceptive"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:ebf982a4-0f98-434b-89ad-cc89cadf3ac6",
"timestamp": "2025-05-23T19:03:10-04:00",
"total": 1,
"contains": [
{
"system": "http://hl7.org/fhir/sid/icd-10-cm",
"version": "2025",
"code": "Z30.46",
"display": "Encounter for surveillance of implantable subdermal contraceptive"
}
]
}
}